Use of Albuterol Multidose Dry Powder Inhaler in Participants With Chronic Obstructive Pulmonary Disease
- Study Title
- Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Participants With Chronic Obstructive Pulmonary Disease (COPD)
- Teva Identifier
- ABS-COPD-30065
- ClinicalTrials.gov Identifier
- NCT03256695
- Study Status
- Completed
- Trial Condition(s)
- Chronic Obstructive Pulmonary Disease
- Interventions
- Drug: Albuterol sulfate (ABS)
Study Description
Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Adult, Older Adult
- Age Range
- 40 Years and older
- Trial Duration
- September 28, 2017 - April 17, 2018
- Phase
- Phase 3
